Decision Making Under Explicit Risk is Impaired in Individuals with Human Immunodeficiency Virus (HIV)
Overview
Affiliations
Introduction: Human immunodeficiency virus (HIV) can affect the frontal-striatal brain regions, which are known to subserve decision-making functions. Previous studies have reported impaired decision making among HIV+ individuals using the Iowa Gambling Task, a task that assesses decision making under ambiguity. Previous study populations often had significant comorbidities such as past or present substance use disorders and/or hepatitis C virus coinfection, complicating conclusions about the unique contributions of HIV-infection to decision making. Decision making under explicit risk has very rarely been examined in HIV+ individuals and was tested here using the Game of Dice Task (GDT).
Method: We examined decision making under explicit risk in the GDT in 20 HIV+ individuals without substance use disorder or HCV coinfection, including a demographically matched healthy control group (n = 20). Groups were characterized on a standard neuropsychological test battery. For the HIV+ group, several disease-related parameters (viral load, current and nadir CD4 T-cell count) were included. Analyses focused on the GDT and spanned between-group (t-tests; analysis of covariance, ANCOVA) as well as within-group comparisons (Pearson/Spearman correlations).
Results: HIV+ individuals were impaired in the GDT, compared to healthy controls (p = .02). Their decision-making impairments were characterized by less advantageous choices and more random choice strategies, especially towards the end of the task. Deficits in the GDT in the HIV+ group were related to executive dysfunctions, slowed processing/motor speed, and current immune system status (CD4+ T-cell levels, ps < .05).
Conclusions: Decision making under explicit risk in the GDT can occur in HIV-infected individuals without comorbidities. The correlational patterns may point to underlying fronto-subcortical dysfunctions in HIV+ individuals. The GDT provides a useful measure to assess risky decision making in this population and should be tested in larger studies.
Ripamonti E, Clerici M Top Antivir Med. 2021; 29(3):386-396.
PMID: 34370420 PMC: 8384087.
Hall S, Towe S, Nadeem M, Hobkirk A, Hartley B, Li R J Neurovirol. 2021; 27(3):463-475.
PMID: 33983505 PMC: 8276275. DOI: 10.1007/s13365-021-00981-1.
Effects of cocaine and HIV on decision-making abilities.
Nigro S, Wu M, Juliano A, Flynn B, Lu L, Landay A J Neurovirol. 2021; 27(3):422-433.
PMID: 33978905 PMC: 8380473. DOI: 10.1007/s13365-021-00965-1.
Nass S, Hahn Y, McLane V, Varshneya N, Damaj M, Knapp P Brain Behav Immun Health. 2020; 5.
PMID: 33083793 PMC: 7571616. DOI: 10.1016/j.bbih.2020.100077.
Neural sensitivity to risk in adults with co-occurring HIV infection and cocaine use disorder.
Bell R, Towe S, Lalee Z, Huettel S, Meade C Cogn Affect Behav Neurosci. 2020; 20(4):859-872.
PMID: 32648056 PMC: 7773226. DOI: 10.3758/s13415-020-00806-4.